Akari Therapeutics PlcMost RecentCompany & Industry OverviewsWhy Akari Therapeutics Soared YesterdayThe 12-month consensus recommendation for Akari Therapeutics is a “strong buy.”
Company & Industry OverviewsWhy Akari Therapeutics Soared YesterdayThe 12-month consensus recommendation for Akari Therapeutics is a “strong buy.”